Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01482091 · ClinicalTrials.gov registry record · Phase 4
Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis
A Phase 4 study of Pain and Anemia, Sickle Cell, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT01482091 is a Phase 4 study of Pain and Anemia, Sickle Cell that has completed, run by Montefiore Medical Center. The registered enrollment target is 124 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01482091, a Phase 4 study of Pain and Anemia, Sickle Cell, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if intranasal fentanyl can decrease the pain of patients with sickle cell disease who present to the pediatric emergency department with a vaso-occlusive crisis.
Conditions Studied
Interventions
- DRUG Normal Saline
- DRUG Fentanyl Citrate
Study Locations (1)
New York
- Children's Hospital at Montefiore - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2011-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01482091
The ClinicalTrials.gov registry entry for NCT01482091 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (59% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Normal Saline is the first listed.
NCT01482091 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01482091 about?
NCT01482091 is a clinical study titled "Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis". The purpose of this study is to determine if intranasal fentanyl can decrease the pain of patients with sickle cell disease who present to the pediatric emergency department with a vaso-occlusive crisis.
What is the current status of trial NCT01482091?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 124 participants. The study started on 2011-12.
What conditions does trial NCT01482091 study?
This clinical trial studies the following conditions: Pain, Anemia, Sickle Cell.
What interventions are being tested in trial NCT01482091?
The interventions under investigation include: Normal Saline (DRUG), Fentanyl Citrate (DRUG).
Who is sponsoring clinical trial NCT01482091?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01482091 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.